In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Call for Technology and Innovation

EHRA 2023, Barcelona & Online from 16 to 18 April


the call for Technology and Innovation is now closed.

The results will be announced mid-February. 

For clinicians, scientists or engineers.

The invention or innovation should be on the broad topic of cardiac arrhythmias and tackle a novel approach. It could be a developed software, a new device, a new use for a drug or other small molecule, or bringing a business approach to an aspect of cardiac rhythm management that can be considered an invention.

All pre-commercial revenue stages will be considered, so the idea may be still in basic research, or have progressed all the way to early clinical trials, but it should have moved beyond the idea stage.


Key dates

  • Monday, 25 October 2021 - Wednesday, 12 January 2022:  Submission period
  • Wednesday 19 January 2022 - Extended submission deadline
  • Mid-February: Results announcement. An email will also be sent to each submitter.

Preparing your submission

Format of the session

The top three presenters will present their innovation during 12 minutes followed by 5 minutes discussion. 

Instructions and guidelines concerning the presentation will be provided to the presenters at the time of results announcement, including the options for presentation in person at the congress venue in Copenhagen, Denmark.


The top three presenters will be awarded a free registration to attend EHRA 2022 and EHRA 2023.